ストックスクリーナーアプリを入手
279.02
0.13%
0.64
Cencora Inc (COR) 最新ニュース
JPMorgan Adjusts Price Target on Cencora to $326 From $301, Maintains Overweight Rating - marketscreener.com
Beat the Market the Zacks Way: Limbach, Stride, Cencora in Focus - Yahoo Finance
Is It Smart To Buy Cencora, Inc. (NYSE:COR) Before It Goes Ex-Dividend? - Yahoo Finance
Cencora, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance
Cencora increases FY2025 EPS guidance to $15.70-$15.95 amid specialty growth - MSN
Here's Why Cencora (COR) is a Strong Momentum Stock - Yahoo Finance
Cencora (COR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Cencora Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Citigroup Maintains Buy Rating and Raises Price Target for Cencora (COR) | COR Stock News - GuruFocus
Cencora (COR) Reaches New Heights with Increased Price Target | COR Stock News - GuruFocus
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Cencora (COR) Receives Increased Price Target from Baird Analyst | COR Stock News - GuruFocus
Cencora (COR) Price Target Increased as U.S. Results Impress | COR Stock News - GuruFocus
Cencora Inc (COR) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Raised Full-Year ... - Yahoo Finance
Cencora Earnings: Strong Utilization and GLP-1s Maintain Growth Momentum and RCA Expands Margins - Morningstar
Cencora Inc (COR) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Raised Full-Year Guidance - GuruFocus
Cencora, Inc. Reports Strong Q2 2025 Results - TipRanks
Earnings call transcript: Cencora Inc Q1 2025 beats earnings expectations, stock surges - Investing.com Nigeria
Cencora: Fiscal Q2 Earnings Snapshot - Midland Daily News
Cencora’s Earnings Call: Strong Growth Amid Challenges - TipRanks
Earnings call transcript: Cencora Inc Q1 2025 beats earnings expectations, stock surges By Investing.com - Investing.com South Africa
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Q2 2025 slides: adjusted EPS jumps 16.3%, guidance raised By Investing.com - Investing.com South Africa
Cencora Enjoys Strong Momentum From GLP-1s, Healthy Utilization Trends, and Growing Specialty Assets - Morningstar
Cencora (NYSE:COR) Sees Strong Q2 Earnings Surge; Declares US$0.55 Dividend - simplywall.st
Jim Cramer Rediscovers Love For Magnificent 7 & Discusses These 11 Stocks - Insider Monkey
Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings - Benzinga
Jim Cramer on Cencora, Inc. (COR): ‘Middleman Money Machine Silences the Doubters’ - MSN
Cencora, Inc. SEC 10-Q Report - TradingView
COR Q2 Earnings & Revenues Beat Estimates, '25 EPS Guidance Raised - TradingView
Transcript : Cencora, Inc., Q2 2025 Earnings Call, May 07, 2025 - marketscreener.com
Cencora Inc (COR) Sees Significant Stock Price Increase | COR Stock News - GuruFocus
Cencora raises annual profit forecast on strong demand for specialty drugs - Reuters
Cencora, Inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:COR) - Seeking Alpha
Cencora Ups Profit Forecast Thanks To Drug Demand - Finimize
Cencora Exceeds EPS Estimates, Achieves Revenue Goals in Q1 2025News and Statistics - IndexBox
Cencora Q2 2025 slides: adjusted EPS jumps 16.3%, guidance raised - Investing.com
Cencora (COR) Misses Q2 Revenue Expectations but Highlights Strong Market Role | COR Stock News - GuruFocus
Cencora (COR) Updates FY25 Guidance with Focus on U.S. Earnings Growth | COR Stock News - GuruFocus
Cencora Reports Strong Q2 2025 Financial Results - TipRanks
Cencora Inc (COR) Q2 2025 Earnings: EPS Surpasses Estimates at $3.68, Revenue Falls Short at $75.5 Billion - GuruFocus
Cencora Inc earnings beat by $0.36, revenue topped estimates - Investing.com South Africa
Cencora Reports Fiscal 2025 Second Quarter Results | COR Stock News - GuruFocus
Earnings Flash (COR) CENCORA Posts Q2 Adjusted EPS $4.42, vs. FactSet Est of $4.11 - marketscreener.com
Cencora, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025 - marketscreener.com
Unveiling Cencora (COR) Q2 Outlook: Wall Street Estimates for Key Metrics - MSN
Will Speciality and GLP-1 Drugs Help COR Beat Q2 Earnings Estimates? - TradingView
Those who invested in Cencora (NYSE:COR) five years ago are up 253% - simplywall.st
Cencora to support US launch of Neurotech’s cell therapy, ENCELTO - Ophthalmology Times
Cencora (COR) Earnings Expected to Grow: Should You Buy? - Yahoo
UBS Adjusts Price Target on Cencora to $335 From $298, Maintains Buy Rating - marketscreener.com
Cencora, Inc. : The resistance should give in - marketscreener.com
0.27%
0.50%
大文字化:
|
ボリューム (24 時間):